The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


Published online August 26, 2009
The Journal of Immunology, 2009, 183, 3625 -3633
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0901571

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jimmunol.0901571v1
183/6/3625    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Devilder, M.-C.
Right arrow Articles by Scotet, E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devilder, M.-C.
Right arrow Articles by Scotet, E.

Early Triggering of Exclusive IFN-{gamma} Responses of Human V{gamma}9V{delta}2 T Cells by TLR-Activated Myeloid and Plasmacytoid Dendritic Cells1

Marie-Claire Devilder, Sophie Allain, Christelle Dousset, Marc Bonneville2 and Emmanuel Scotet2

INSERM, U892, Centre de Recherche en Cancérologie Nantes-Angers, Nantes, France

{gamma}{delta} T cells, a major innate-like T cell subset, are thought to play in vivo an important role in innate and adaptive immune responses to various infection agents like parasites, bacteria, or viruses but the mechanisms contributing to this immune process remain ill defined. Owing to their ability to recognize a broad set of microbial molecular patterns, TLRs represent a major innate pathway through which pathogens induce dendritic cells (DC) maturation and acquisition of immunostimulatory functions. In this study, we studied the effects of various TLR ligands on the activation of human V{gamma}9V{delta}2 T cells, a main human {gamma}{delta} PBL subset, which has been recently involved in the licensing of mycobacteria-infected DC. Both TLR3 and TLR4, but not TLR2 ligands, induced a rapid, strong, and exclusive IFN-{gamma} production by V{gamma}9V{delta}2 T cells. This {gamma}{delta} subset contributed to a large extent to the overall PBL IFN-{gamma} response induced after short-term TLR stimulation of human PBMC. Importantly, this phenomenon primarily depended on type I IFN, but not IL-12, produced by monocytic DC upon TLR engagement. V{gamma}9V{delta}2 T cells were similarly activated by plasmacytoid DC upon TLR8/9 activation or Yellow Fever virus infection. Moreover TLR-induced V{gamma}9V{delta}2 IFN-{gamma} noncytolytic response led to efficient DC polarization into IL-12p70-producing cells. Our results support an adjuvant role played by V{gamma}9V{delta}2 T cells along microbial infections through a particular cross-talk with pathogen-associated molecular patterns-activated DC. Moreover they provide new insights into the mechanisms underlying functional activation of this unique peripheral innate-like T cell subset during viral infections.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by institutional grants from Institut National de la Santé et de la Recherche Médicale (INSERM), Agence Nationale de la Recherche (ANR no. A05118GS), Association pour la Recherche sur le Cancer (ARC no. 3662 and no. 4953) and from the Commission of the European Union Program: TB-VAC (LSHP-CT-2003–503367) and Cancer Immunotherapy (E06005NP/EEA06004GNP).

2 Address correspondence and reprint requests to Emmanuel Scotet or Marc Bonneville, Institut de Recherche Thérapeutique de l’Université de Nantes, Centre de Recherche en Cancérologie Nantes-Angers, INSERM UMR 892, 8 quai Moncousu, BP 70721, Nantes, France. E-mail addresses: Emmanuel.Scotet{at}inserm.fr or bonnevil{at}inserm.fr

3 Abbreviations used in this paper: DC, dendritic cell; iNKT, invariant NKT; BrHPP, bromohydrin pyrophosphate/Phosphostim; YF, yellow fever; iDC, immature DC; ABP, aminobisphophonate; pDC, plasmacytoid DC; moDC, myeloid DC derived from GM-CSF/IL-4-treated monocytes.

4 The online version of this article contains supplemental material.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.